[Semi OT] GTC holders may find this week’s SemBioSys CC on plant-derived insulin to be of interest, especially the remarks about the FDA’s attitude toward the program. The webcast can be accessed at: <A HREF="http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=1694880" target="_blank">http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=1694880</A>